Paul Banim

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 677 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 409 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 281 citations · Full text

Veterinary Medicine, Immunology, Gastroenterology +16

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

Rebecca C. Fitzgerald, Massimiliano di Pietro, Maria O’Donovan et al. · The Lancet · 2020 · 253 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 163 citations · Full text

Medicine, Internal Medicine, Hepatology +9